What specific action they are taking in Europe to further their policy objective of securing the continuing availability on general retail sale of safe higher dose vitamin and mineral supplements. [HL 2277].

What specific action they are taking in Europe to further their policy objective of securing the continuing availability on general retail sale of safe higher dose vitamin and mineral supplements. [HL 2277].

Whether they will identify the authors of the three letters that they have received supporting the proposals that they have received supporting the proposals outlined in the Medicines Control Agency consultation document, MLX249; and whether they will indicate what changes they intend to make to those proposals to take account...

Whether they will identify the authors of the three letters that they have received supporting the proposals that they have received supporting the proposals outlined in the Medicines Control Agency consultation document, MLX249; and whether they will indicate what changes they intend to make to those proposals to take account...

What information they have concerning the outcome of the recent meetings at the European Commission at which possible amendments were considered to European Union Directive 75/318. [HL 2276].

What information they have concerning the outcome of the recent meetings at the European Commission at which possible amendments were considered to European Union Directive 75/318. [HL 2276].

What policy principles determine their approach to the regulation of herbal remedies in the United Kingdom and in Europe. [HL 1893].

What policy principles determine their approach to the regulation of herbal remedies in the United Kingdom and in Europe. [HL 1893].

What are the nature and scope of the proposed forthcoming recommendations from the European Commission for possible amendments to European Union Directive 75/318 in relation to herbal remedies; and why the Commission have not made their proposals publicly available. [HL 1892].

What are the nature and scope of the proposed forthcoming recommendations from the European Commission for possible amendments to European Union Directive 75/318 in relation to herbal remedies; and why the Commission have not made their proposals publicly available. [HL 1892].

Whether a date has yet been fixed for the inquest of Mr John Callaghan, who died in Strangeways prison on 7 May 1996, while awaiting psychiatric assessment. [HL3343].

Whether a date has yet been fixed for the inquest of Mr John Callaghan, who died in Strangeways prison on 7 May 1996, while awaiting psychiatric assessment. [HL3343].

Which scientific papers were taken into account by the Committee of Toxicity and the Food Advisory Committee in making their recommendations relating to vitamin B6 supplementation, and which of those papers have conclusions which have not been challenged elsewhere in the scientific literature. - Includes ref to list of the...

Which scientific papers were taken into account by the Committee of Toxicity and the Food Advisory Committee in making their recommendations relating to vitamin B6 supplementation, and which of those papers have conclusions which have not been challenged elsewhere in the scientific literature. - Includes ref to list of the...

What information they have concerning the number of British people who have taken higher dose vitamin B6 supplements in each of the last 10 years for which figures are available; and whether they will indicate for each of those years the numbers of incidences of death or serious adverse reaction...

What information they have concerning the number of British people who have taken higher dose vitamin B6 supplements in each of the last 10 years for which figures are available; and whether they will indicate for each of those years the numbers of incidences of death or serious adverse reaction...

What representations about the ban on higher dose vitamin B6 they have received from Dr John Hathcock or other former directors of the United States Food and Drug Administration; and whether any such representations supported or opposed the introduction of the ban.

What representations about the ban on higher dose vitamin B6 they have received from Dr John Hathcock or other former directors of the United States Food and Drug Administration; and whether any such representations supported or opposed the introduction of the ban.